Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Applied DNA Sciences (APDN) stocks in Canada

Learn how to easily invest in Applied DNA Sciences stocks.

Applied DNA Sciences is a diagnostics & research business based in the US. Applied DNA Sciences stocks (APDN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.7 – a decrease of 10.74% over the previous week. Applied DNA Sciences employs 78 staff and has a trailing 12-month revenue of around $9 million.

How to buy shares in Applied DNA Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – APDN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Applied DNA Sciences stock price (NASDAQ:APDN)

Use our graph to track the performance of APDN stocks over time.

Applied DNA Sciences shares at a glance

Information last updated 2022-01-25.
Latest market close$3.49
52-week range$3.20 - $13.64
50-day moving average $4.76
200-day moving average $5.66
Wall St. target price$16.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.07

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Applied DNA Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Applied DNA Sciences price performance over time

Historical closes compared with the close of $3.49 from 2022-01-26

1 week (2022-01-21) -5.68%
1 month (2021-12-28) -18.08%
3 months (2021-10-28) -36.55%
6 months (2021-07-28) -33.78%
1 year (2021-01-28) -64.57%
2 years (2020-01-28) -10.28%
3 years (2019-01-28) 636.44%
5 years (2017-01-27) 83.68%

Applied DNA Sciences financials

Revenue TTM $9 million
Gross profit TTM $4.9 million
Return on assets TTM -59.65%
Return on equity TTM -169.76%
Profit margin -158.25%
Book value $1.49
Market capitalisation $25.2 million

TTM: trailing 12 months

Applied DNA Sciences share dividends

We're not expecting Applied DNA Sciences to pay a dividend over the next 12 months.

Have Applied DNA Sciences's shares ever split?

Applied DNA Sciences's shares were split on a 1:40 basis on 31 October 2019. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Applied DNA Sciences shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Applied DNA Sciences shares which in turn could have impacted Applied DNA Sciences's share price.

Applied DNA Sciences share price volatility

Over the last 12 months, Applied DNA Sciences's shares have ranged in value from as little as $3.2 up to $13.64. A popular way to gauge a stock's volatility is its "beta".

APDN.US volatility(beta: 0.92)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied DNA Sciences's is 0.9235. This would suggest that Applied DNA Sciences's shares are less volatile than average (for this exchange).

Applied DNA Sciences overview

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site